期刊文献+
共找到171篇文章
< 1 2 9 >
每页显示 20 50 100
THE GRAVY TRAIN
1
作者 LAN XINZHEN 《Beijing Review》 2007年第35期22-23,共2页
The Qinghai-Tibet Railway, the highest rail in the world, was hailed as a miracle of engineeringwhen it began running a year ago. Today, it isbeing hailed for the economic benefits it hasbrought to the once isolated r... The Qinghai-Tibet Railway, the highest rail in the world, was hailed as a miracle of engineeringwhen it began running a year ago. Today, it isbeing hailed for the economic benefits it hasbrought to the once isolated region of 展开更多
关键词 THE gravy TRAIN
原文传递
Mild diarrhea leading to tacrolimus toxicity in an immunocompromised patient with suspected community-acquired pneumonia:a case report
2
作者 Xueying Chen Jianbo Ding +3 位作者 Jiali Zhang Hongyan Jiang Haibin Dai Lingyan Yu 《World Journal of Emergency Medicine》 2025年第2期174-176,共3页
Tacrolimus (TAC) is increasingly used for immunosuppression in organ transplantation,dermatomyositis/polymyositis,and myasthenia gravis(MG) patients.^([1]) TAC has a narrow therapeutic window with overexposure leading... Tacrolimus (TAC) is increasingly used for immunosuppression in organ transplantation,dermatomyositis/polymyositis,and myasthenia gravis(MG) patients.^([1]) TAC has a narrow therapeutic window with overexposure leading to acute and chronic forms of adverse reactions (ADRs).After oral administration,TAC is predominantly absorbed in the duodenum and jejunum and has highly variable pharmacokinetics,particularly when diarrhea occurs.^([2,3]) Few data has been published on TAC overexposure following mild diarrhea.Mild diarrhea is relatively common and often unreported,which can easily be overlooked by physicians,especially in the emergency department.Here,we report the occurrence of serious ADRs to TAC after mild diarrhea in a MG patient with community-acquired pneumonia(CAP),including nephrotoxicity,metabolic abnormalities and severe immunosuppression. 展开更多
关键词 DIARRHEA PNEUMONIA GRAVIS
暂未订购
重症肌无力的临床研究现状 被引量:11
3
作者 王丽芳 毛梅 +2 位作者 张宇(综述) 邓晖 冯加纯(审校) 《中风与神经疾病杂志》 CAS 北大核心 2016年第1期82-85,共4页
重症肌无力(myasthenia gravis,MG)是一种神经肌肉接头传递障碍的自身免疫性疾病,其病变部位在突触后膜,主要表现为骨骼肌易疲劳。除了我们熟知的症状,MG患者还会出现不安腿综合征(restless legs syndrome,RLS)、睡眠障碍性呼吸(sl... 重症肌无力(myasthenia gravis,MG)是一种神经肌肉接头传递障碍的自身免疫性疾病,其病变部位在突触后膜,主要表现为骨骼肌易疲劳。除了我们熟知的症状,MG患者还会出现不安腿综合征(restless legs syndrome,RLS)、睡眠障碍性呼吸(sleep-disordered breathing,SDB)及嗅觉、听觉、认知等非运动症状。MG自身免疫性抗体是目前临床研究的热点,MG的临床分型也倾向于与不同抗体类型有关。 展开更多
关键词 重症肌无力 运动症状 自身免疫性抗体 MYASTHENIA GRAVIS 自身免疫性疾病 睡眠障碍性呼吸 ACHR 不安腿综合征 突触后膜
暂未订购
Sixty cases of ocular myasthenia gravis treated with acupuncture and moxibustion at extra-meridian and collateral 被引量:4
4
作者 陈金亮 潘朝 +1 位作者 刘艳君 LIU Zhao 《World Journal of Acupuncture-Moxibustion》 2012年第4期56-59,共4页
Objective To explore effective therapeutic method for the treatment of ocular myasthenia gravis. Methods Sixty cases of ocular myasthenia gravis were selected. The acupuncture was applied at Dàzhuī (大椎 GV 14... Objective To explore effective therapeutic method for the treatment of ocular myasthenia gravis. Methods Sixty cases of ocular myasthenia gravis were selected. The acupuncture was applied at Dàzhuī (大椎 GV 14), Bǎihuì (百会 GV 20), Shàngxīng (上星 GV 23) of Governor Vessel, and its crossing points with Yinqiao and Yangqiao Meridian, such as Jīngmíng (睛明 BL 1), shēnmài (申脉 BL 62), Dìcāng (地仓 ST 4), Jūliáo (巨髎 ST 3), Chéngqì (承泣 ST 1 ), etc. Besides, ginger-partition moxibustion was applied at Yángbái (阳白 GB 14) and Sìbái (四白 ST 2). The plum-blossom needle was applied at upper limb distribution of lung channel of hand taiyin, heart channel of hand shaoyin and pericardium channel of hand jueyin. The patients’ clinical symptoms, potential degradation percentages of repetitive nerve stimulation (RNS) in low frequency were observed. Results 8 cases were clinically cured, 20 cases were basically cured, 12 cases were remarkably effective, 15 cases were effective and 5 cases were failed. The total effective rate was 91.7%. Compared with before the treatment, the potential degradation percentages of repetitive nerve stimulation in low frequency were lowered [(19.44±6.28)% vs (8.78±3.12)%, (P0.05)]. Conclusion Acupuncture and moxibustion at extra-meridian and collateral for ocular myasthenia gravis could achieve positive efficacy. 展开更多
关键词 ocular myasthenia gravis acupuncture therapy extra-meridian and collateral plum-blossom needle prick
原文传递
中西医结合治疗重症肌无力临床疗效和安全性的Meta分析 被引量:13
5
作者 双晓萍 谭子虎 +2 位作者 陈乞 陈子薇 陈丽珠 《中国中医药科技》 CAS 2016年第1期121-124,共4页
重症肌无力(myasthenia gravis,MG)是一种自身免疫性疾病[1-2]。中医药工作者对MG展开了大量的研究工作,体现出中医药独特的优势及前景。为此,笔者全面收集中西医结合治疗MG的临床随机对照试验,进行Meta分析,以期为临床实践提供可靠... 重症肌无力(myasthenia gravis,MG)是一种自身免疫性疾病[1-2]。中医药工作者对MG展开了大量的研究工作,体现出中医药独特的优势及前景。为此,笔者全面收集中西医结合治疗MG的临床随机对照试验,进行Meta分析,以期为临床实践提供可靠依据。1资料与方法1.1文献来源中国知识资源总库(CNKI)、万方学术期刊全文数据库、维普中文期刊数据库(VIP)、中国生物医学文献服务系统(CBM)作为资料源,包括其公开发表于国内医学期刊及未发表的文献资料如学术报告、会议论文集或毕业论文等。 展开更多
关键词 重症肌无力 META分析 中西医结合 中文期刊数据库 MYASTHENIA 学术期刊全文 GRAVIS 中医药工作者 自身免疫性疾病 绝对评分
暂未订购
术后放疗在胸腺瘤中的作用及研究进展 被引量:4
6
作者 贾佳 李月敏 《实用医学杂志》 CAS 北大核心 2016年第15期2573-2575,共3页
胸腺瘤(thymic tumor,TT)位于前纵膈内、来源于胸腺上皮,是一种潜在恶性生长且相对惰性的罕见肿瘤,约占所有恶性肿瘤的0.2%~1.5%。常发生在40~70岁,儿童罕见约占10%。根据2004年WHO病理组织学分型,TT分为(A,AB,B1,B2和B3型)或TC... 胸腺瘤(thymic tumor,TT)位于前纵膈内、来源于胸腺上皮,是一种潜在恶性生长且相对惰性的罕见肿瘤,约占所有恶性肿瘤的0.2%~1.5%。常发生在40~70岁,儿童罕见约占10%。根据2004年WHO病理组织学分型,TT分为(A,AB,B1,B2和B3型)或TC(已被单列)。目前Masaoka-Koga分期为TT的最新分期,但临床上仍以Masaoka分期(Ⅰ~Ⅳ期)为标准。 展开更多
关键词 胸腺瘤 术后放疗 组织学分型 纵膈 腺上皮 肌无力危象 MYASTHENIA 重症肌无力 GRAVIS 重离子
暂未订购
调节性T细胞和辅助性T细胞17细胞失衡在重症肌无力中的研究进展 被引量:4
7
作者 陈渊 张鹏 《实用医学杂志》 CAS 北大核心 2016年第15期2578-2580,共3页
重症肌无力(myasthenia gravis,MG)是自身抗体直接作用于神经肌肉街头引起的以肌肉无力为临床特征的一种自身免疫性疾病。主要的抗原靶点为乙酰胆碱受体(acetylcholine receptor,ACh R),其次为肌肉特异性激酶(muscle-specific kina... 重症肌无力(myasthenia gravis,MG)是自身抗体直接作用于神经肌肉街头引起的以肌肉无力为临床特征的一种自身免疫性疾病。主要的抗原靶点为乙酰胆碱受体(acetylcholine receptor,ACh R),其次为肌肉特异性激酶(muscle-specific kinase,Mu SK)和低密度脂蛋白受体相关蛋白4(low density lipoprotein receptor-related protein 4,LRP4)。 展开更多
关键词 重症肌无力 自身免疫性疾病 MYASTHENIA 神经肌肉 GRAVIS 乙酰胆碱受体 胸腺组织 自身抗体 免疫调节 细胞分化
暂未订购
硫唑嘌呤治疗晚发型重症肌无力的疗效 被引量:2
8
作者 李平 李双英 张巧莲 《实用医学杂志》 CAS 北大核心 2016年第10期1725-1726,共2页
重症肌无力(myasthenia gravis)是一种获得性自身免疫性疾病,一般认为发病年龄有2个高峰,分为早发型和晚发型。但近年临床资料显示,晚发型重症肌无力(late-onset myasthenia gravis,LOMG)的发病呈增高趋势。
关键词 重症肌无力 晚发型 MYASTHENIA GRAVIS 硫唑嘌呤 自身免疫性疾病 发病年龄 新斯的明试验 四肢肌肉 糖皮质激素
暂未订购
Histologic Classification of Thymoma and Its Relationship with Myasthenia Gravis and Clinical Stages of the Tumor 被引量:1
9
作者 王新允 陈云新 +1 位作者 王爱香 张淑敏 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第5期314-316,327,共4页
Objective: To investigate the relationship among the latest WHO classification of thymoma, myasthenia gravis (MG) and clinical stages. Methods: To review the pathological sections of 74 patients with thymoma from ... Objective: To investigate the relationship among the latest WHO classification of thymoma, myasthenia gravis (MG) and clinical stages. Methods: To review the pathological sections of 74 patients with thymoma from 1980-2004 using WHO classification (1999), the statistical software was used to analyze the relationship among the WHO classification, MG and clinical stages. Results: (1) Two cases of type A, 23 cases of type AB, 4 cases of type B1, 27 cases of type B2, 16 cases of type B3 and 2 cases of type C were classified. Type B2 more likely accompanied MG (P〈0.05), while none with MG occurred for type C. (2) One patient was in stage Ⅰ, 30 were in stage Ⅱ, 38 were in stage Ⅲ, and 5 were in stage Ⅳ. The latest histologic classification was significantly correlated with Masaoka stages (P〈0.01). Conclusion: The latest WHO classification was correlated with occurrence of MG and finely reflected clinical stage. It can also evaluate the prognosis of patients. 展开更多
关键词 THYMOMA myasthenia gravis clinical stages
暂未订购
重症肌无力的治疗进展 被引量:1
10
作者 于磊 徐严明 徐萍蓉 《华西医学》 CAS 2008年第6期1510-1511,共2页
关键词 重症肌无力 胸腺切除术 ACHR 乙酰胆碱受体 血浆交换 MYASTHENIA GRAVIS 眼肌型 自身免疫性疾病 胸腺组织
原文传递
重症肌无力相关抗体及与胸腺疾病相关性的研究进展 被引量:1
11
作者 张哲峰 金凤 薛雷 《中风与神经疾病杂志》 CAS 北大核心 2015年第10期957-958,共2页
重症肌无力(myathenia gravis,MG)是由T细胞辅助、抗体介导并有补体参与的一种神经-肌肉接头传递功能障碍的获得性自身免疫性疾病。它是神经肌肉传导疾病中较为常见的疾病,患者可表现为波动性的肌无力,易疲劳和晨轻暮重症状。在绝大... 重症肌无力(myathenia gravis,MG)是由T细胞辅助、抗体介导并有补体参与的一种神经-肌肉接头传递功能障碍的获得性自身免疫性疾病。它是神经肌肉传导疾病中较为常见的疾病,患者可表现为波动性的肌无力,易疲劳和晨轻暮重症状。在绝大多数情况下,骨骼肌乙酰胆碱受体(AChR)成为自身免疫攻击靶点,然而也存在其它的攻击靶点比如肌肉特异性受体酪氨酸激酶(Mu SK)。 展开更多
关键词 重症肌无力 攻击靶点 胸腺疾病 自身免疫性疾病 ACHR 神经肌肉 乙酰胆碱受体 胸腺瘤 GRAVIS 神经-肌肉接头
暂未订购
儿童重症肌无力合并桥本甲状腺炎1例报道 被引量:1
12
作者 杨均 李作孝 《重庆医学》 CAS 北大核心 2015年第21期3023-3024,共2页
重症肌无力(myasthenia gravis,MG)是神经肌肉接头疾病中常见的一种,各个年龄阶段均可发病,儿童患者合并桥本甲状腺炎(Hashimoto′s thyroiditis,HT)临床上较少见。1临床资料患者,女,10岁,患者于3个月前无明显原因出现视物成双,向... 重症肌无力(myasthenia gravis,MG)是神经肌肉接头疾病中常见的一种,各个年龄阶段均可发病,儿童患者合并桥本甲状腺炎(Hashimoto′s thyroiditis,HT)临床上较少见。1临床资料患者,女,10岁,患者于3个月前无明显原因出现视物成双,向左注视时明显,并进行性加重。2个月前出现右侧眼睑下垂,伴晨轻暮重,被动睁眼时伴有视物成双。 展开更多
关键词 儿童重症肌无力 桥本甲状腺炎 视物成双 MYASTHENIA GRAVIS 神经肌肉接头 THYROIDITIS 新斯的明试验 晨轻暮重 胸腺切除术
暂未订购
ANCA阳性的重症肌无力合并桥本甲状腺炎、周围性面瘫1例 被引量:1
13
作者 关文娟 王天舒 +2 位作者 景黎君 滕军放 贾延劼 《国际神经病学神经外科学杂志》 2014年第6期529-530,共2页
重症肌无力(myasthenia gravis,MG)是神经内科常见的自身免疫性疾病,以受累肌肉的无力、易疲劳为主要表现,可以合并Graves病、桥本甲状腺炎、系统性红斑狼疮、吉兰-巴雷综合征等多种自身免疫性疾病。但到目前为止,国内尚无MG合并桥本... 重症肌无力(myasthenia gravis,MG)是神经内科常见的自身免疫性疾病,以受累肌肉的无力、易疲劳为主要表现,可以合并Graves病、桥本甲状腺炎、系统性红斑狼疮、吉兰-巴雷综合征等多种自身免疫性疾病。但到目前为止,国内尚无MG合并桥本甲状腺炎(Hashimoto’s thyroiditis,HT),同时又合并ANCA阳性和周围性面瘫的报道。本文就新近收治的一例合并多种抗体阳性的MG患者进行分析,旨在提高对本病的进一步认识。 展开更多
关键词 ANCA阳性 桥本甲状腺炎 重症肌无力 周围性面瘫 自身免疫性疾病 MYASTHENIA gravis THYROIDITIS 系统性红斑狼疮 新斯的明试验
暂未订购
Identification and Physiochemical Analysis of ERK Interacting Proteins Using Bio-Computational Tools 被引量:1
14
作者 Khuleshwari Kurrey Vijay Paramanik 《World Journal of Neuroscience》 2018年第2期303-313,共11页
ERK (Extracellular Signal Regulated Kinase) or MAP kinase is an intracellular signaling molecule. ERK is involved in regulation of various functions i.e. cell proliferation, cell migrations, cell survival and many mor... ERK (Extracellular Signal Regulated Kinase) or MAP kinase is an intracellular signaling molecule. ERK is involved in regulation of various functions i.e. cell proliferation, cell migrations, cell survival and many more. It gets activated in response of various stimuli like growth factors, cytokines, virus, second messengers, transforming agents and carcinogens. While transferring signals from cell surface receptors to cell nucleus, ERK interacts with a numbers of proteins. Physiochemical and functional characterization of these proteins is little known. Thus, we attempted to study physiochemical and functional properties of ERK interacting proteins using bio-computational tools. ExPASy and SOSUI server suggested 22 ERK interacting proteins. Physical and chemical parameters of these ERK interacting partners indicated higher percentage of hydrophobic amino acid and leucine as major constituent. Moreover, the instability index indicated that four proteins are stable in over wide range temperature in vitro, and remaining eighteen proteins were found unstable. In addition, SOSUI server showed that fifteen proteins were soluble and six are trans-membrane in nature. 展开更多
关键词 EXTRACELLULAR SIGNAL Regulated KINASE (ERK) gravy SOSUI STRING STITCH ExPASy
暂未订购
Th17在重症肌无力发病机制中作用的研究进展
15
作者 金迪 李颖 付锦 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第9期1272-1274,共3页
重症肌无力(Myasthenia gravis,MG)是一种神经肌肉接头传递障碍的获得性自身免疫性疾病。病变主要累及神经-肌肉接头突触后膜上乙酰胆碱受体(Acetylcholine receptor,AChR),临床特征为部分或全身骨骼肌极易疲劳,晨轻暮重,休息和胆... 重症肌无力(Myasthenia gravis,MG)是一种神经肌肉接头传递障碍的获得性自身免疫性疾病。病变主要累及神经-肌肉接头突触后膜上乙酰胆碱受体(Acetylcholine receptor,AChR),临床特征为部分或全身骨骼肌极易疲劳,晨轻暮重,休息和胆碱酯酶抑制剂治疗后有效。 展开更多
关键词 重症肌无力 TH17 ACHR 乙酰胆碱受体 GRAVIS 神经-肌肉接头 突触后膜 自身免疫性疾病 全身骨骼肌 晨轻暮重
暂未订购
声嘶为首发症状的晚发型重症肌无力1例
16
作者 殷鹏 阮晓敏 +1 位作者 蒋志毅 司马国旗 《中国耳鼻咽喉头颈外科》 北大核心 2006年第9期628-628,共1页
重症肌无力(myasthenia grayis,MG)是发生于青壮年的自身免疫性疾病,近60%的患者在20~40岁之间发病[1].50岁以后发病的情况少见.本文报告1例老年晚发型MG患者.
关键词 声嘶(Hoarseness) 重症肌无力(Myasthenia Gravis)
暂未订购
实验性自身免疫性重症肌无力模型构建方法进展 被引量:7
17
作者 许骏尧 陈以狄 +3 位作者 程杨 孙佳玥 朱洁 吴颢昕 《中国免疫学杂志》 CAS CSCD 北大核心 2016年第3期428-431,共4页
重症肌无力(Myasthenia gravis,MG)是在细胞免疫依赖性补体参与下,由乙酰胆碱受体抗体(Acetylcholine receptor antibody,AChR Ab)介导而产生的自身免疫系统疾病。位于神经肌肉接头(Neuromuscular junction,NMJ)处的AChR是导致MG... 重症肌无力(Myasthenia gravis,MG)是在细胞免疫依赖性补体参与下,由乙酰胆碱受体抗体(Acetylcholine receptor antibody,AChR Ab)介导而产生的自身免疫系统疾病。位于神经肌肉接头(Neuromuscular junction,NMJ)处的AChR是导致MG的自身免疫抗原。 展开更多
关键词 重症肌无力 ACHR GRAVIS 肌无力症状 细胞免疫 大鼠 转基因小鼠 免疫抗原 神经肌肉接头 电鳐
暂未订购
Research advancement in immunopathogenesis of myasthenia gravis 被引量:2
18
作者 黄莎 谭利明 《Neuroscience Bulletin》 SCIE CAS CSCD 2010年第1期85-89,共5页
Myasthenia gravis (MG) is an autoimmune neuromuscular junction disease mediated by antibodies against the acetylcholine receptor (AChR). The etiology and immunopathogenesis of MG remain unclear. Recent research ha... Myasthenia gravis (MG) is an autoimmune neuromuscular junction disease mediated by antibodies against the acetylcholine receptor (AChR). The etiology and immunopathogenesis of MG remain unclear. Recent research has shown the involvement of autoantibodies, lymphocytes, cytokines and chemokines, in the pathogenesis of MG. Systematic factors are also demonstrated, such as inheritance and endocrine. This review indicates the research development in immunopathogenesis of MG. 展开更多
关键词 myasthenia gravis immunological pathogenesis
原文传递
Surgical approaches for stage Ⅰ and Ⅱ thymoma-associated myasthenia gravis:feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy in comparison with trans-sternal resection 被引量:17
19
作者 Zhicheng He Quan Zhu +3 位作者 Wei Wen Liang Chen Hai Xu Hai Li 《The Journal of Biomedical Research》 CAS 2013年第1期62-70,共9页
Complete resection could be achieved in virtually all myasthenic patients with Masaoka stage I and II thymoma us- ing the trans-sternal technique. Whether this is appropriate for minimally invasive approach is not yet... Complete resection could be achieved in virtually all myasthenic patients with Masaoka stage I and II thymoma us- ing the trans-sternal technique. Whether this is appropriate for minimally invasive approach is not yet clear. We evalu- ated the feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy for the treatment of Ma- saoka stage I and Ⅱ thymoma-associated myasthenia gravis, compared to conventional trans-sternal thymectomy. We summarized 33 patients with Masaoka stage I and II thymoma-associated myasthenia gravis between April 2006 and September 2011. Of these, 15 patients underwent right-sided complete VATS (the VATS group) by us- ing adjuvant pneuomomediastinum, comparing with 18 patients using the trans-sternal approach (the T3b group). No intraoperative death was found and no VATS case required conversion to median sternotomy. Significant differences between the two groups regarding duration of surgery and volume of intraoperative blood loss (P = 0.001 and P 〈 0.001, respectively) were observed. Postoperative morbidities were 26.7% and 33.3% for the VATS and T3b groups, respectively. All 33 patients were followed up for 12 to 61 months in the study. The cumulative probabilities of reaching complete stable remission and effective rate were 26.7% (4/15) and 93.3% (14/15) in the VATS group, which had a significantly higher complete stable remission and effective rate than those in the T3b group (P = 0.026 and P = 0.000, respectively). We conclude that VATS thymectomy utilizing adjuvant pneuomo- mediastinum for the treatment of stage I and II thymoma-associated myasthenia gravis is technically feasible but deserves further investigation in a large series with long-term follow-up. 展开更多
关键词 video-assisted thoracoscopic surgery (VATS) THYMOMA THYMECTOMY myasthenia gravis adjuvantpneuomomediastinum
暂未订购
FcRn inhibitors:a novel option for the treatment of myasthenia gravis 被引量:10
20
作者 Li-Na Zhu Hai-Man Hou +4 位作者 Sai Wang Shuang Zhang Ge-Ge Wang Zi-Yan Guo Jun Wu 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第8期1637-1644,共8页
Myasthenia gravis is an acquired,humoral immunity-mediated autoimmune disease characterized by the production of autoantibodies that impair synaptic transmission at the neuromuscular junction.The intervention-mediated... Myasthenia gravis is an acquired,humoral immunity-mediated autoimmune disease characterized by the production of autoantibodies that impair synaptic transmission at the neuromuscular junction.The intervention-mediated clearance of immunoglobulin G(IgG)was shown to be effective in controlling the progression of the disease.The neonatal Fc receptor(FcRn)plays a key role in prolonging the serum half-life of IgG.Antagonizing FcRn to prevent its binding to IgG can accelerate the catabolism of the latter,resulting in decreased levels of IgG,including pathogenic autoantibodies,thereby achieving a therapeutic effect.In this review,we detail the substantial research progress,both basic and clinical,relating to the use of FcRn inhibitors in the treatment of myasthenia gravis. 展开更多
关键词 batoclimab clinical trial efgartigimod FCRN FcRn inhibitors immunoglobulin G(IgG) myasthenia gravis nipocalimab rozanolixizumab
暂未订购
上一页 1 2 9 下一页 到第
使用帮助 返回顶部